Series of Fourteen Cases of Topical Imiquimod 5% in Lentigo Maligna: Treatment Modalities and Clues for Detecting Recurrences
Topical imiquimod has been used off-label as monotherapy or adjuvant treatment for lentigo maligna. Our aim is to describe treatment modalities, clinical outcomes, and management of recurrence in patients receiving imiquimod for lentigo maligna.Patients from our unit with lentigo maligna or lentigo...
Saved in:
Main Authors: | I. Poveda-Montoyo (Author), P. Álvarez-Chinchilla (Author), L. Schneller-Pavelescu (Author), P. Hispán-Ocete (Author), J. Bañuls-Roca (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
[Artículo traducido] Serie de 14 casos de tratamiento con imiquimod tópico al 5% en lentigo maligno: modalidades terapéuticas y claves para detectar recidivas
by: I. Poveda-Montoyo, et al.
Published: (2022) -
Topical Imiquimod Treatment of Lentigo Maligna
by: F. Ventura, et al.
Published: (2009) -
Effectiveness of 5% Topical Imiquimod for Lentigo Maligna Treatment
by: Darryl C.K.S. Tio, et al.
Published: (2019) -
Topical Treatment of Melanoma In Situ, Lentigo Maligna, and Lentigo Maligna Melanoma with Imiquimod Cream: A Systematic Review of the Literature
by: Silvia Vaienti, et al.
Published: (2023) -
Remissão de lentigo maligno extenso após tratamento com imiquimod Remission of extensive lentigo maligna after treatment with imiquimod
by: Christiane D. Piazza, et al.
Published: (2009)